The Commercial Trajectory of Biologics and Monoclonal Antibodies:...

σε πρόσθεσε στο άλλο

2026-04-17 05:16:25 - Μετάφραση -

The Commercial Trajectory of Biologics and Monoclonal Antibodies: Analyzing 2026 Trends in B-Cell Depletion and Cytokine Inhibition (2026–2032)

Market Overview and Size (2025 Forecast) As of 2024, the global Antisynthetase Syndrome Market was valued at USD 235.56 million. Moving into 2025, the market is benefiting from a wave of new diagnostic protocols and the off-label use of advanced biologics. The market is projected to grow to USD 382.59 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of...

0 Σχόλια 0 Μοιράστηκε 655 Views 0 Προεπισκόπηση